Non inferiority
Methods of defining the non inferiority margin in randomized, double blind controlled trials: a systematic review
9
New Tests for Assessing Non Inferiority and Equivalence from Survival Data
10
The use of randomisation based efficacy estimators in non inferiority trials
11
Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: study protocol of a non inferiority, randomized controlled trial
10
Phase IV non-inferiority trials and additional claims of benefit
5
Efficacy and safety of single injection of cross linked sodium hyaluronate vs three injections of high molecular weight sodium hyaluronate for osteoarthritis of the knee: a double blind, randomized, multi center, non inferiority study
10
Non inferiority versus superiority drug claims: the (not so) subtle distinction
5
Multicentre study evaluating the non inferiority of the new paediatric formulation of artesunate/amodiaquine versus artemether/lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Senegal
8
Sample sizes for non-inferiority studies based on the difference between two proportions: a unified approach for difference, ratio and odds ratio models
29
A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy
17
An experienced physiotherapist prescribing and administering corticosteroid and local anaesthetic injections to the shoulder in an Australian orthopaedic service, a non inferiority randomised controlled trial and economic analysis: study protocol for a randomised controlled trial
9
Hysteropexy in the treatment of uterine prolapse stage 2 or higher: a multicenter randomized controlled non-inferiority trial comparing laparoscopic sacrohysteropexy with vaginal sacrospinous hysteropexy (LAVA-trial, study protocol)
7
Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial
8
The impact of maintaining serum potassium ≥3 6 mEq/L vs ≥4 5 mEq/L on the incidence of new onset atrial fibrillation in the first 120 hours after isolated elective coronary artery bypass grafting – study protocol for a randomised feasibility trial for the proposed Tight K randomized non inferiority trial
9
Quality of reporting of clinical non inferiority and equivalence randomised trials update and extension
12
Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non unions of the tibia and femur: study protocol of a randomized controlled non inferiority trial
9
Through the looking glass: understanding non inferiority
12
A non-inferiority study to analyze the safety of totally tubeless percutaneous nephrolithotomy
6
Practical guide to sample size calculations: non-inferiority and equivalence trials
20
A multi centre, non inferiority, randomised controlled trial to compare a cervical pessary with a cervical cerclage in the prevention of preterm delivery in women with short cervical length and a history of preterm birth – PC study
9